Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 20% ± 4% | |
glutamatergic neuron | 3 studies | 25% ± 7% |
Insufficient scRNA-seq data for expression of DGKQ at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1902.61 | 1445 / 1445 | 100% | 24.22 | 183 / 183 |
pancreas | 100% | 1330.80 | 328 / 328 | 100% | 27.40 | 178 / 178 |
intestine | 100% | 3752.35 | 966 / 966 | 100% | 36.51 | 525 / 527 |
prostate | 100% | 2410.04 | 245 / 245 | 99% | 17.21 | 499 / 502 |
thymus | 100% | 2343.64 | 653 / 653 | 99% | 16.28 | 601 / 605 |
stomach | 100% | 1606.97 | 359 / 359 | 99% | 28.53 | 284 / 286 |
bladder | 100% | 2048.00 | 21 / 21 | 99% | 24.40 | 499 / 504 |
uterus | 100% | 2078.85 | 170 / 170 | 99% | 18.83 | 453 / 459 |
skin | 100% | 2504.43 | 1809 / 1809 | 99% | 24.80 | 465 / 472 |
brain | 99% | 3034.34 | 2611 / 2642 | 99% | 17.83 | 701 / 705 |
breast | 100% | 1743.68 | 459 / 459 | 98% | 17.52 | 1098 / 1118 |
lung | 100% | 2408.87 | 577 / 578 | 98% | 19.08 | 1132 / 1155 |
adrenal gland | 100% | 1867.52 | 258 / 258 | 96% | 12.71 | 220 / 230 |
kidney | 100% | 1820.61 | 89 / 89 | 95% | 11.54 | 856 / 901 |
liver | 100% | 1051.31 | 226 / 226 | 93% | 12.23 | 379 / 406 |
ovary | 100% | 1526.99 | 180 / 180 | 93% | 11.81 | 399 / 430 |
adipose | 100% | 1615.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 25.45 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.32 | 29 / 29 |
spleen | 100% | 3784.19 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.61 | 1 / 1 |
blood vessel | 100% | 1678.79 | 1331 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 22.64 | 44 / 45 |
peripheral blood | 97% | 2094.33 | 905 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 841.26 | 823 / 861 | 0% | 0 | 0 / 0 |
muscle | 67% | 403.38 | 535 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0090181 | Biological process | regulation of cholesterol metabolic process |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_1900242 | Biological process | regulation of synaptic vesicle endocytosis |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_1903432 | Biological process | regulation of TORC1 signaling |
GO_0033198 | Biological process | response to ATP |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_2000182 | Biological process | regulation of progesterone biosynthetic process |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0046339 | Biological process | diacylglycerol metabolic process |
GO_0019933 | Biological process | cAMP-mediated signaling |
GO_0046486 | Biological process | glycerolipid metabolic process |
GO_0070493 | Biological process | thrombin-activated receptor signaling pathway |
GO_2000064 | Biological process | regulation of cortisol biosynthetic process |
GO_0046834 | Biological process | lipid phosphorylation |
GO_0006111 | Biological process | regulation of gluconeogenesis |
GO_0030168 | Biological process | platelet activation |
GO_0010801 | Biological process | negative regulation of peptidyl-threonine phosphorylation |
GO_0051591 | Biological process | response to cAMP |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0006654 | Biological process | phosphatidic acid biosynthetic process |
GO_0070528 | Biological process | protein kinase C signaling |
GO_0007205 | Biological process | protein kinase C-activating G protein-coupled receptor signaling pathway |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005730 | Cellular component | nucleolus |
GO_0098793 | Cellular component | presynapse |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0012506 | Cellular component | vesicle membrane |
GO_0016607 | Cellular component | nuclear speck |
GO_0098794 | Cellular component | postsynapse |
GO_0016363 | Cellular component | nuclear matrix |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005768 | Cellular component | endosome |
GO_0005634 | Cellular component | nucleus |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0019900 | Molecular function | kinase binding |
GO_0043274 | Molecular function | phospholipase binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0047649 | Molecular function | alkylglycerol kinase activity |
GO_0004143 | Molecular function | ATP-dependent diacylglycerol kinase activity |
GO_0030297 | Molecular function | transmembrane receptor protein tyrosine kinase activator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DGKQ |
Protein name | Diacylglycerol kinase (DAG kinase) (EC 2.7.1.107) Diacylglycerol kinase theta (DAG kinase theta) (DGKtheta) (EC 2.7.1.107) (EC 2.7.1.93) (Diglyceride kinase theta) (DGK-theta) Diacylglycerol kinase theta |
Synonyms | DAGK4 |
Description | FUNCTION: Diacylglycerol kinase that converts diacylglycerol/DAG into phosphatidic acid/phosphatidate/PA and regulates the respective levels of these two bioactive lipids . Thereby, acts as a central switch between the signaling pathways activated by these second messengers with different cellular targets and opposite effects in numerous biological processes . Within the adrenocorticotropic hormone signaling pathway, produces phosphatidic acid which in turn activates NR5A1 and subsequent steroidogenic gene transcription . Also functions downstream of the nerve growth factor signaling pathway being specifically activated in the nucleus by the growth factor (By similarity). Through its diacylglycerol activity also regulates synaptic vesicle endocytosis . . |
Accessions | D6RJB4 H0Y8Q7 ENST00000509465.5 ENST00000510286.1 H0YA20 ENST00000515182.1 ENST00000273814.8 P52824 |